The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.
F.D.A. to Relabel Leucovorin for Autism Treatment
Featured Articles
Search
Author Details
Jenifer Propets
Lorem ipsum dolor sit amet, adipiscing elit, sed do eiusmod tempor ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.